Template:Congestive heart failure: Difference between revisions

	Congestive heart failure Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Congestive heart failure from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Clinical Assessment
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Cardiac MRI
Echocardiography
Exercise Stress Test
Myocardial Viability Studies
Cardiac Catheterization
Endomyocardial biopsy
Treatment
Invasive Hemodynamic Monitoring
Medical Therapy: Acute Pharmacotherapy Chronic Pharmacotherapy: Diuretics ACE Inhibitors Angiotensin receptor blockers Aldosterone Antagonists Beta Blockers Ca Channel Blockers Nitrates Hydralazine Positive Inotropics Anticoagulants Antiarrhythmic Drugs Nutritional Supplements Omega-3-Fatty Acid Hormonal Therapies Drugs to Avoid Drug Interactions Treatment of underlying causes Associated conditions
Exercise Training
Surgical Therapy: Biventricular Pacing or Cardiac Resynchronization Therapy (CRT) Implantation of Intracardiac Defibrillator Ultrafiltration Cardiac Surgery Left Ventricular Assist Devices (LVADs) Cardiac Transplantation
ACC/AHA Guideline Recommendations Hospitalized Patients Patients With a Prior MI Sudden Cardiac Death Prevention Patients at high risk for developing heart failure (Stage A) Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B) Patients with current or prior symptoms of heart failure (Stage C) Patients with refractory end-stage heart failure (Stage D)
Implementation of Practice Guidelines
Congestive heart failure end-of-life considerations
Specific Groups: Special Populations Patients who have concomitant disorders Obstructive Sleep Apnea in the Patient with CHF
Congestive heart failure On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Congestive heart failure
CDC on Congestive heart failure
Congestive heart failure in the news
Blogs on Congestive heart failure
Directions to Hospitals Treating Congestive heart failure
Risk calculators and risk factors for Congestive heart failure

VisualWikitext

@@ Line 200: / Line 200: @@
 |- bgcolor="PaleTurquoise"
 !
-ACCF/AHA Guideline for the Management of Heart Failure
+ACC/AHA Guideline Recommendations
-: [[2013 ACCF/AHA Guideline Definition of HF|Definitions of HFrEF and HFpEF]]
-: [[2013 ACCF/AHA Guideline Initial and Serial Evaluation of the HF Patient|Evaluation of the HF]]
-: [[2013 ACCF/AHA Guideline Treatment of Stages A to D|At high risk for HF but without structural heart disease or symptoms of HF (Stage A)]]
-: [[2013 ACCF/AHA Guideline Treatment of Stages A to D|Structural heart disease but without signs or symptoms of HF (Stage B)]]
-: [[2013 ACCF/AHA Guideline Treatment of Stages A to D|Structural heart disease with prior or current symptoms of HF (Stage C)]]
-: [[2013 ACCF/AHA Guideline Treatment of Stages A to D|Refractory HF requiring specialized interventions (Stage D)]]
-: [[2013 ACCF/AHA Guideline The Hospitalized Patient|Hospitalized Patient]]
-: [[2013 ACCF/AHA Guideline Surgical/Percutaneous/Transcather Interventional Treatments of HF|Surgical/Percutaneous/Transcather Interventional Treatments]]
-: [[2013 ACCF/AHA Guideline Coordinating Care for Patients With Chronic HF|Coordinating Care]]
-: [[2013 ACCF/AHA Guideline Quality Metrics/Performance Measures|Quality Metrics/Performance Measures]]
-|- bgcolor="PaleTurquoise"
-!
-ACC/AHA Guideline Recommendations
 : [[Congestive heart failure AHA recommendations for hospitalized patient|Hospitalized Patients]]
 : [[Congestive heart failure AHA recommendations for patients with a prior MI|Patients With a Prior MI]]

Template:Congestive heart failure: Difference between revisions

Revision as of 00:43, 9 August 2013

Navigation menu